Ferritin blood test: what low and high results mean

Most iron is used in hemoglobin, while ferritin stores iron inside cells and releases it when needed. The small amount of ferritin measured in blood usually tracks iron reserves. Transferrin saturation answers a different question: how much of the iron-transport protein is carrying iron at that time.^{See reference 11,See reference 22,See reference 88}

The interval on the report shows how that laboratory flags the result; it is a useful first check, not the final clinical boundary. A clinical cutoff is a decision aid chosen for a defined population and purpose. Neither is a universal healthy target, and the number must be interpreted with the method, age, sex, pregnancy, anemia and inflammatory context.^{See reference 11,See reference 22,See reference 1010,See reference 1111}

The WHO thresholds above come from population guidance; RCPA, AGA and BSG cutoffs come from specific clinical settings. Their differences are intentional, not evidence that one number is universally correct.^{See reference 11,See reference 22,See reference 33,See reference 44,See reference 55}

The rows below are conversation guides, not diagnoses. They show why the same ferritin category can mean different things when hemoglobin, iron availability or inflammation changes.

Absolute iron deficiency means iron stores are depleted. Functional iron deficiency means iron is present but inflammation or disease makes less of it available to tissues. Both can overlap.

Ferritin is an acute-phase protein, so inflammation can raise it and hide depleted or poorly available iron. Transferrin saturation and an inflammatory marker can clarify the pattern, but the clinical history remains essential.^{See reference 11,See reference 22,See reference 33,See reference 99,See reference 1414}

Iron stores can fall through loss, increased need, inadequate intake or poor absorption. More than one mechanism can be present, and treatment without investigating the cause can miss an important source of blood loss.^{See reference 22,See reference 33,See reference 44,See reference 1515}

Fatigue can occur with iron deficiency before anemia. Weakness, reduced exercise tolerance, headaches or restless legs can also occur, but they are nonspecific and do not reveal a ferritin number.^{See reference 88,See reference 1717}

Ferritin rises with inflammation and cell injury as well as iron storage. Common causes include recent infection or inflammation, fatty liver and other liver injury, alcohol-related liver stress, metabolic dysfunction, kidney disease and some cancers. Genetic or secondary iron overload is important, but ferritin alone cannot confirm it.^{See reference 11,See reference 66,See reference 77,See reference 1414}

A common first-line review includes repeat ferritin, transferrin saturation, complete blood count, creatinine and liver tests, plus alcohol, metabolic, inflammatory and family history. A transferrin saturation below 45% generally makes iron overload less likely in the cited primary-care pathway, while persistent elevation at or above 45% needs the wider context.^{See reference 77}

In the European Association for the Study of the Liver (EASL) haemochromatosis pathway, biochemical thresholds are sex- and disease-specific and are combined with transferrin saturation and HFE gene context. They are diagnostic pathway triggers—not healthy-population targets. Likewise, treatment ferritin goals used after a haemochromatosis diagnosis must never be applied to someone simply trying to optimize a routine result.^{See reference 66}

A persistent ferritin above 1,000 ng/mL (1,000 µg/L) warrants prompt clinical evaluation, particularly with abnormal liver tests, but the number still does not identify the cause or emergency level by itself. Seek urgent care based on symptoms: chest pain, severe or worsening breathlessness, fainting, heavy active bleeding, vomiting blood, new black tarry stools with weakness, severe symptoms in pregnancy, or feeling acutely very unwell should not wait for an online ferritin interpretation.^{See reference 77}

After oral treatment, guidelines often check the hemoglobin response within the first few weeks and continue follow-up after hemoglobin normalizes to assess replenishment and recurrence. Ferritin can be temporarily high after intravenous iron, so use the repeat schedule from the treating service rather than choosing an early check independently.^{See reference 33,See reference 1515}

A useful plan begins with the reason iron became low or ferritin became high. Food choices can support iron intake, but ongoing bleeding, pregnancy, inflammation or malabsorption may need medical treatment that diet alone cannot provide. Iron can also be harmful when it is not needed.

The AGA expert review supports oral iron as a common first step and intravenous iron when oral treatment is not tolerated, does not improve stores or is unlikely to be absorbed. The exact formulation and schedule depend on the person and clinical pathway, so they are deliberately not prescribed here.^{See reference 1515}

When oral iron is appropriate, the same review advises dosing no more than once daily and notes that every-other-day dosing may be better tolerated for some people with similar absorption. A clinician should still choose the formulation and schedule for the cause, response, other medicines and side effects.^{See reference 1515}

Advice on vitamin C is mixed. The AGA expert review suggests it can improve absorption, while a randomized trial of 440 adults with iron-deficiency anemia found oral iron alone equivalent to oral iron plus vitamin C for blood response and iron-store recovery. Vitamin C is therefore not a universal requirement.^{See reference 1515,See reference 1616}

Trial evidence suggests iron replacement may modestly improve fatigue in some non-anemic adults with confirmed iron deficiency, while objective physical-performance benefits are less certain. That does not make fatigue a ferritin diagnosis or justify treatment without confirmed deficiency.^{See reference 1717}

A systematic review found lower average ferritin among women with nonscarring alopecia, but the included studies were heterogeneous and did not validate one treatment target. Thyroid disease, recent illness, childbirth, energy restriction, medicines, androgen-related hair loss and scalp disease can produce overlapping concerns.^{See reference 1212}

These shortcuts conflict with the known effects of inflammation, disease-specific decision thresholds, iron-loading pathways and assay variation.^{See reference 11,See reference 22,See reference 66,See reference 77,See reference 1010,See reference 1111}

These labels summarize current international and specialty guidance, assay-comparison research, treatment evidence and the hair-loss literature.^{See reference 11,See reference 22,See reference 33,See reference 66,See reference 77,See reference 1010,See reference 1111,See reference 1212,See reference 1515,See reference 1616,See reference 1717}